References
- 1. Abecassis M, Bartlett ST, Collins AJ, et al. Kid-Hu S, Ming P, Qureshi AR, Lindholm B, Bo Y, Yang H. Peritonitis: Episode Sequence, Microbiological Variation, Risk Factors and Clinical Outcomes in a North China Peritoneal Dialysis Center. Kidney Blood Press Res. 2018; 43(5): 1573–84.10.1159/000494443
- 2. Grassmann A, Gioberges S, Moeller S, Brown G. ESRD patients in 2004: global overview of patient numbers, treatment modalities and associated trends. Nephrol Dial Transplant. 2005; 20: 2587–9310.1093/ndt/gfi159
- 3. Li PK, Chow KM, Van de Luijtgaarden MW, Johnson DW, Jager KJ, Mehrotra R, et al. Changes in the worldwide epidemiology of peritoneal dialysis. Nat Rev Nephrol. 2017 Feb; 13(2): 90–103.10.1038/nrneph.2016.181
- 4. Cho Y, Johnson DW. Peritoneal dialysis-related peritonitis: towards improving evidence, practices, and outcomes. Am J Kidney Dis. 2014 Aug; 64(2): 278–89.10.1053/j.ajkd.2014.02.025
- 5. Nochaiwong S, Ruengorn C, Koyratkoson K, Thavorn K, Awiphan R, Chaisai C, et al. Thai Renal Outcomes Research (THOR) Investigators. A Clinical Risk Prediction Tool for Peritonitis-Associated Treatment Failure in Peritoneal Dialysis Patients. Sci Rep. 2018 Oct 4; 8(1): 1479710.1038/s41598-018-33196-2
- 6. de Moraes TP, Figueiredo AE, de Campos LG, Olandoski M, Barretti P, Pecoits-Filho R; BRAZ-PD Investigators. Characterization of the BRAZ-PD II cohort and description of trends in peritoneal dialysis outcome across time periods. Perit Dial Int. 2014 Nov-Dec; 34(7): 714–23.10.3747/pdi.2013.00282
- 7. Boudville N, Kemp A, Clayton P, Lim W, Badve SV, Hawley CM, et al. Recent peritonitis associates with mortality among patients treated with peritoneal dialysis. J Am Soc Nephrol 2012; 23: 1398–40510.1681/ASN.2011121135
- 8. Nishina M, Yanagi H, Kakuta T, Endoh M, Fukagawa M, Takagi A: A 10-year retrospective cohort study on the risk factors for peritoneal dialysis-related peritonitis: a single-center study at Tokai University Hospital. Clin Exp Nephrol 2014; 18: 649–65410.1007/s10157-013-0872-y
- 9. Tian Y, Xie X, Xiang S, Yang X, Lin J, Zhang X, et al. Risk Factors and Outcomes of Early-Onset Peritonitis in Chinese Peritoneal Dialysis Patients. Kidney Blood Press Res. 2017; 42(6): 1266–76.10.1159/000485930
- 10. Fang W, Qian J, Lin A, Rowaie F, Ni Z, Yao Q, et al. Comparison of peritoneal dialysis practice patterns and outcomes between a Canadian and a Chinese centre. Nephrol Dial Transplant. 2008 Dec; 23(12): 4021–28.10.1093/ndt/gfn372
- 11. Mujais S. Microbiology and outcomes of peritonitis in North America. Kidney Int Suppl. 2006 Nov; (103): S55–62.10.1038/sj.ki.5001916
- 12. Ghali JR, Bannister KM, Brown FG, Rosman JB, Wiggins KJ, Johnson DW, et al. Microbiology and outcomes of peritonitis in Australian peritoneal dialysis patients. Perit Dial Int. 2011 Nov-Dec; 31(6): 651–62.10.3747/pdi.2010.00131
- 13. Szeto CC, Li PK, Johnson DW, Bernardini J, Dong J, Figueiredo AE, et al. ISPD Catheter-Related Infection Recommendations: 2017 Update. Perit Dial Int. 2017 Mar–Apr; 37(2): 141–54.10.3747/pdi.2016.00120
- 14. Li PK, Szeto CC, Piraino B, de Arteaga J, Fan S, Figueiredo AE, et al. ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment. Perit Dial Int. 2016 Sep 10; 36(5): 481–508.10.3747/pdi.2016.00078
- 15. Ye H, Zhou Q, Fan L, Guo Q, Mao H, Huang F, et al. The impact of peritoneal dialysis-related peritonitis on mortality in peritoneal dialysis patients. BMC Nephrol. 2017 Jun 5; 18(1): 186.10.1186/s12882-017-0588-4
- 16. Hsieh YP, Chang CC, Wen YK, Chiu PF, Yang Y. Predictors of peritonitis and the impact of peritonitis on clinical outcomes of continuous ambulatory peritoneal dialysis patients in Taiwan--10 years' experience in a single center. Perit Dial Int. 2014 Jan-Feb; 34(1): 85–94.10.3747/pdi.2012.00075
- 17. Klarić D, Knotek M. Long-term effects of peritonitis on peritoneal dialysis outcomes. Int Urol Nephrol 2013; 45: 519–2510.1007/s11255-012-0257-2
- 18. Cheung AK, Sarnak MJ, Yan G, Berkoben M, Heyka R, Kaufman A, et al.; HEMO Study Group. Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study. Kidney Int. 2004 Jun; 65(6): 2380–9.10.1111/j.1523-1755.2004.00657.x
- 19. Perl J, Fuller DS, Bieber BA, Boudville N, Kanjanabuch T, Ito Y, et al. Peritoneal Dialysis-Related Infection Rates and Outcomes: Results From the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS). Am J Kidney Dis. 2020 Jul; 76(1): 42–53.10.1053/j.ajkd.2019.09.016
- 20. Burke M, Hawley CM, Badve SV, McDonald SP, Brown FG, Boudville N, et al. Relapsing and re-current peritoneal dialysis-associated peritonitis: a multicenter registry study. Am J Kidney Dis. 2011 Sep; 58(3): 429–36.10.1053/j.ajkd.2011.03.022
- 21. van Esch S, Krediet RT, Struijk DG. 32 years' experience of peritoneal dialysis-related peritonitis in a university hospital. Perit Dial Int. 2014 Mar-Apr; 34(2): 162–70.10.3747/pdi.2013.00275
- 22. Salzer WL. Peritoneal dialysis-related peritonitis: challenges and solutions. Int J Nephrol Renovasc Dis. 2018 Jun 11; 11: 173–86.10.2147/IJNRD.S123618
- 23. Wang HH, Huang CH, Kuo MC, Lin SY, Hsu CH, Lee CY,et al. Microbiology of peritoneal dialysis-related infection and factors of refractory peritoneal dialysis related peritonitis: A ten-year single-center study in Taiwan. J Microbiol Immunol Infect. 2019 Oct; 52(5): 752–59.10.1016/j.jmii.2018.10.013
- 24. Prasad N, Gupta A. Fungal peritonitis in peritoneal dialysis patients. Perit Dial Int. 2005 May-Jun; 25(3): 207–22.10.1177/089686080502500302
- 25. Restrepo C, Chacon J, Manjarres G. Fungal peritonitis in peritoneal dialysis patients: successful prophylaxis with fluconazole, as demonstrated by prospective randomized control trial. Perit Dial Int. 2010 Nov–Dec; 30(6): 619–25.10.3747/pdi.2008.00189
- 26. Kavanagh D, Prescott GJ, Mactier RA. Peritoneal dialysis-associated peritonitis in Scotland (1999–2002). Nephrol Dial Transplant. 2004 Oct; 19(10): 2584–91.10.1093/ndt/gfh386